Targeted drug could benefit young patients with invasive sarcoma

A collaborative research team, led by scientists at VCU Massey Comprehensive Cancer Center and Huntsman Cancer Institute at the University of Utah, has identified a targeted drug that could effectively treat an aggressive soft tissue cancer that occurs most often in pediatric and young adult patients.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup